Latest Breaking News On - பல்கலைக்கழகம் மருத்துவ மையம் அட்ரெக்ட் - Page 12 : comparemela.com

ExEm® Foam, the only FDA-approved contrast agent for ultrasound tubal patency testing, now available in the U S

Share this article Share this article NASHVILLE, Tenn., Feb. 17, 2021 /PRNewswire/ ExEm® Foam Inc announced today that ExEm® Foam ((air polymer-type A) intrauterine foam), the only FDA-approved contrast agent for ultrasound tubal patency testing, is now available at select fertility clinics nationwide. The Foam procedure, a new ultrasound technique of hysterosalpingo foam sonography (HyFoSy), uses ExEm® Foam to assess whether there may be a blockage in the fallopian tubes in women with known or suspected infertility. The innovative imaging technique offers a less complicated and less invasive alternative to laparoscopy and dye, the gold standard for diagnosing tubal patency. The outpatient tubal assessment is also associated with significantly lower pain scores as compared to the standard of care, X-ray hysterosalpingography (HSG), and does not require the use of radiation and iodine.

Zuid hollandJohan remmerswaalMark hans emanuelJack shanagherUniversity medical center utrechtWomen healthDrug administrationDepartment gynecologyFoam incExem foam incProfessor mark hans emanuelReproductive medicineExem foamHealth care amp hospitalsMedical pharmaceuticalsMedical equipment

Oncimmune PLC continues building momentum with partnerships

Oncimmune PLC continues building momentum with partnerships
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomAugmenta bioworksAdam hillsUniversity medical center utrechtNational health service early cancer detection testNorfolk waveney clinical commissioning groupLung health checkHealth economicNational health serviceEarly cancer detection test lung scotlandWaveney clinical commissioningHealth checkCalifornia based augmenta bioworksEuropean respiratory journalஒன்றுபட்டது கிஂக்டம்பண்படாமனித இயல்பு மலைகள்

Researchers assess cognitive impairment in patients with breast cancer

E-Mail A recent analysis of published studies estimates that one-quarter of adults with breast cancer have cognitive impairment before starting therapy. The analysis, which is published in Psycho-Oncology, also found that many patients cognitive function declines after receiving chemotherapy, endocrine therapy, and/or hormone therapy for breast cancer. Our results suggest that cancer-related and personal factors may make a significant contribution to cognitive functioning, said lead author Aicha Dijkshoorn, of the University Medical Center Utrecht, in the Netherlands. The authors noted that the findings from different studies were quite diverse, and some even reported cognitive improvements in patients after treatment. They stressed the importance of evaluating and addressing cognitive function, ideally over time, in patients with breast cancer.

Aicha dijkshoornUniversity medical center utrechtCancer dayபல்கலைக்கழகம் மருத்துவ மையம் அட்ரெக்ட்புற்றுநோய் நாள்

New analysis highlights prevalence of cognitive impairment and changes in breast cancer patients

New analysis highlights prevalence of cognitive impairment and changes in breast cancer patients
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

Aicha dijkshoornEmily hendersonUniversity medical center utrechtStudy lead authorCancer dayஎமிலி ஹென்டர்சன்பல்கலைக்கழகம் மருத்துவ மையம் அட்ரெக்ட்படிப்பு வழி நடத்து நூலாசிரியர்புற்றுநோய் நாள்

Researchers map heart recovery after heart attack with great detail

E-Mail IMAGE: Shown is an infarcted heart in which green represents cardiomyocytes (heart muscle cells), red shows B2M expression and blue represents cell nuclei. The area deprived of green is the infarcted. view more Credit: Louk Timmer © Hubrecht Institute Researchers from the Hubrecht Institute mapped the recovery of the heart after a heart attack with great detail. They found that heart muscle cells - also called cardiomyocytes - play an important role in the intracellular communication after a heart attack. The researchers documented their findings in a database that is accessible for scientists around the world. This brings the research field a step closer to the development of therapies for improved recovery after heart injury. The results were published in

The netherlandsMarjolein droogJantine monshouwer klootsLouk timmerLoukt timmerEva van rooijLieneke kooijmanIlaria periniDanielle versteegVan rooijUniversity medical center utrechtCommunications biologyHubrecht instituteHesther de ruiterMolecular cardiologyUniversity medical center